‘The Key Challenges: Life Sciences and Healthcare 2020’ is the latest report from Cornerstone International Group based on a global survey of…

So far in 2020 PharmaBoardroom has conducted interviews with several key stakeholders in US healthcare. We have heard from leaders the US FDA, as well…

Layla Sentissi, executive director of AMIP, Morocco’s oldest pharma association, explains the structure of the country’s pharmaceutical industry…

In 2019, several drug companies testified to the US Senate Finance Committee on medicine price hikes with a narrative of discounts given to health…

The United States Trade Representative Office has been engaging with a number of countries, including Mexico, to address concerns related to IP…

Matt Eyles, president and CEO of the Association of Healthcare Insurance Providers (AHIP) outlines how the US health insurance landscape has evolved…

Saudi Arabia is aiming to become a more attractive investment destination for multinational pharma companies through economic development projects…

PharmaBoardroom highlights three pharma executives whose experience in the Middle East has served to propel them into global leadership positions.…

As Egypt rolls out Universal Health Insurance with the aim of achieving full coverage between 2030 and 2035, the domestic pharmaceutical market stands…

The Greater Bay Area's - and in particular, Shenzhen’s - prowess in life sciences manufacturing and development must also be attributed to the…

With non WTO members such as Algeria flouting intellectual property (IP) it raises the issue of how best to protect and price medicines in the future.…

Ai Hua Ong, Company Group Chairman, Asia Pacific, The Janssen Pharmaceutical Companies of Johnson & Johnson. There is a clear…